Dose dense versus 3 weekly AC during neoadjuvant chemoimmunotherapy for triple negative breast cancer.

NPJ Breast Cancer · 2024 · PMC11324725 · PMID 39143082

Europe PMC DOI

hedged sentences

0.0920

closest p · 1.8× alpha

0.1550

boldest claim

The sentences

showed a trendP = 0.092so close (0.05 < p ≤ 0.1)

While no significant disparities in drug discontinuation was noted, ddAC showed a trend towards higher rates of grade ≥3 AE (40.5% vs. 30.7%, P = 0.092).

also in 53,322 other papers

did not reach statistical significanceP = 0.155not close (p > 0.1)

However, the difference did not reach statistical significance ( P = 0.155).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.